Published in J Immunol on September 01, 1985
Immunoprotective Leishmania major synthetic T cell epitopes. J Exp Med (1990) 1.45
Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. Infect Immun (1999) 1.32
Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model. J Exp Med (1997) 1.14
Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma. Clin Exp Immunol (2003) 1.05
Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response. Infect Immun (1994) 1.02
Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection. Infect Immun (2009) 0.95
Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants. Infect Immun (2000) 0.94
Suppression of interleukin-2 production by macrophages in genetically susceptible mice infected with Leishmania major. Infect Immun (1986) 0.92
Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis. Clin Diagn Lab Immunol (2000) 0.90
Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis. Infect Immun (1987) 0.88
Immunization against experimental coccidiosis produces contrasting results in inbred mice of differing susceptibility to infection. Infect Immun (1994) 0.87
Mycobacterium bovis BCG-induced protection against cutaneous and systemic Leishmania major infections of mice. Infect Immun (1987) 0.87
Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK. Infect Immun (2004) 0.86
Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis. Clin Exp Immunol (1989) 0.85
Responses to vaccination in strains of mice that differ in susceptibility to coccidiosis. Infect Immun (1996) 0.84
Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice. Infect Immun (1988) 0.83
Oral vaccination against coccidiosis: responses in strains of mice that differ in susceptibility to infection with Eimeria vermiformis. Infect Immun (1997) 0.81
Protective effect of lectin from Synadenium carinatum on Leishmania amazonensis infection in BALB/c mice. Korean J Parasitol (2007) 0.78
Therapeutic immunization with radio-attenuated Leishmania parasites through i.m. route revealed protection against the experimental murine visceral leishmaniasis. Parasitol Res (2012) 0.77
Intranasal vaccination with leishmanial antigens protects golden hamsters (Mesocricetus auratus) against Leishmania (Viannia) Braziliensis infection. PLoS Negl Trop Dis (2015) 0.77
Immunostimulatory responses to crude extracts of Warburgia ugandensis (Sprague) subsp ugandensis (Canellaceae) by BALB/c mice infected with Leishmania major. Pan Afr Med J (2014) 0.75
Evaluation of s.c. route of immunization by homologous radio attenuated live vaccine in experimental murine model of visceral leishmaniasis. J Parasit Dis (2014) 0.75
Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 6.20
Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med (1997) 4.03
Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med (1998) 3.53
Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice. Infect Immun (1988) 3.44
Pathways in the development of liver macrophages: alternative precursors contained in populations of lymphocytes and bone-marrow cells. Proc R Soc Lond B Biol Sci (1968) 3.00
The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med (1996) 2.99
Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. J Exp Med (1980) 2.97
A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest (1999) 2.65
Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol (1984) 2.57
Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol (1980) 2.54
Studies on immunological paralysis. VI. Thymic-independence of tolerance and immunity to type 3 pneumococcal polysaccharide. Cell Immunol (1971) 2.42
Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med (1998) 2.40
The role of TH1 and TH2 cells in a rodent malaria infection. Science (1993) 2.38
Studies on the induction of immunological unresponsiveness to pneumococcal polysaccharide in mice. J Exp Med (1966) 2.24
Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. J Immunol (1982) 2.21
Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun (1992) 2.08
Properties of macrophage receptors for cytophilic antibodies. Br J Exp Pathol (1966) 2.07
Nitric oxide and asthmatic inflammation. Immunol Today (1995) 2.01
Studies on immunological paralysis. II. The detection and significance of antibod-forming cells in the spleen during immunological paralysis with type 3 pneumococcal polysaccharide. Clin Exp Immunol (1969) 2.01
Functional heterogeneity of CD4+ T cells in leishmaniasis. Immunol Today (1989) 1.97
Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells. Mol Microbiol (1999) 1.95
Regulation of delayed-type hypersensitivity. I. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol (1977) 1.94
Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. Microb Pathog (1987) 1.93
Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J Immunol (1990) 1.90
Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J Exp Med (1972) 1.90
Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol (1978) 1.89
Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol (1994) 1.89
Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection. J Immunol (1982) 1.89
Cellular events in the induction and loss of tolerance to pneumococcal polysaccharides. Transplant Rev (1972) 1.85
Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med (1996) 1.85
Immunological tolerance. Prog Allergy (1975) 1.83
Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol (1992) 1.83
T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin. Nature (1979) 1.82
Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol (1994) 1.82
Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol (1998) 1.81
Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J Immunol (2000) 1.80
Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med (1995) 1.80
Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol (1993) 1.79
A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol (2001) 1.78
T-cell subsets and cytokines in parasitic infections. Immunol Today (1992) 1.77
Immunological regulation and control of experimental leishmaniasis. Int Rev Exp Pathol (1986) 1.75
Genetic analysis of the Escherichia coli FtsZ.ZipA interaction in the yeast two-hybrid system. Characterization of FtsZ residues essential for the interactions with ZipA and with FtsA. J Biol Chem (2001) 1.74
Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice. J Immunol (1976) 1.74
A role for IL-18 in neutrophil activation. J Immunol (2001) 1.72
Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis (2008) 1.70
Monoclonal antibodies to Leishmania tropica major: specificities and antigen location. Parasitology (1982) 1.63
The initial suppression of bacterial growth in a salmonella infection is mediated by a localized rather than a systemic response. Microb Pathog (1987) 1.60
Biological effects of Corynebacterium parvum. IV. Adjuvant and inhibitory activities on B lymphocytes. Cell Immunol (1973) 1.58
Influence of molecular structure on the tolerogenicity of bacterial dextrans. I. The alpha1--6-linked epitope of dextran B512. Immunology (1975) 1.56
Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology (1994) 1.55
A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology (1994) 1.54
Delayed-type hypersensitivity to influenza virus. Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to hemagglutinin during influenza virus infection in mice. J Exp Med (1980) 1.54
Studies on immunological paralysis. IV. The relative contributions of continuous antibody neutralization and central inhibition to paralysis with type 3 pneumococcal polysaccharide. Proc R Soc Lond B Biol Sci (1971) 1.54
Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunol Today (1998) 1.53
Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today (2000) 1.51
Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J Immunol (2001) 1.50
Increasing response rates for mailed surveys of Medicaid clients and other low-income populations. Am J Epidemiol (1999) 1.48
Genetically determined susceptibility to Leishmania tropica infection is expressed by haematopoietic donor cells in mouse radiation chimaeras. Nature (1980) 1.47
Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc Natl Acad Sci U S A (1996) 1.46
Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology (1995) 1.46
Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J Immunol (2000) 1.45
Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. Proc Natl Acad Sci U S A (1998) 1.44
Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol (1998) 1.42
Multigene phylogeny of the Old World mice, Murinae, reveals distinct geographic lineages and the declining utility of mitochondrial genes compared to nuclear genes. Mol Phylogenet Evol (2005) 1.41
Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus. J Immunol (1989) 1.40
Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes. J Immunol (1984) 1.39
Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J Exp Med (1992) 1.38
Role of nitric oxide in the regulation of T cell functions. Ann Rheum Dis (2006) 1.38
Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state. BMC Immunol (2001) 1.37
The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J Exp Med (1996) 1.37
Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides. J Immunol (1991) 1.36
Extra-hepatic derivation of Kupffer cells during oestrogenic stimulation of parabiosed mice. Br J Exp Pathol (1969) 1.35
Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. Immunology (1982) 1.35
Activated macrophages direct apoptosis and suppress mitosis of mesangial cells. J Immunol (2000) 1.34
Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J Immunol (1999) 1.32
Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae. J Immunol (2001) 1.31
Expression of human IL-1 beta in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo. J Immunol (1992) 1.31
Retracted Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages. J Immunol (1993) 1.31
Lack of a correlation between cell-mediated immunity to the carrier and the carrier-hapten helper effect. J Exp Med (1974) 1.30
Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection. J Immunol (1985) 1.29
Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Eur J Immunol (1995) 1.27